Survival rate of advanced stage of triple negative breast cancer

Triple-negative breast cancer is defined as triple-negative breast cancer. The 5-year survival rate of patients with triple-negative breast cancer is relatively low, generally less than 10%.

Triple-negative breast cancer lacks the expression of estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2, which makes it insensitive to endocrine therapy and targeted therapy. Treatment methods are relatively limited, which affects the survival rate to some extent

.